中南建設(000961.SZ):以3.755億元與第三方設合夥企業 進行房地產業務投資
格隆匯5月28日丨中南建設(000961.SZ)公吿,日前,公司全資子公司杭州錦啟置業有限公司(“杭州錦啟”)和廈門中南德譽房地產開發有限公司(“廈門德譽”)作為有限合夥人分別出資3.159億元和0.596億元,與獨立第三方杭州陸晟投資管理有限公司、杭州陸浦投資管理有限公司合作設立嘉興崇昕投資合夥企業(有限合夥),進行房地產業務投資。杭州錦啟和廈門德譽合計投資金額3.755億元,佔公司2020年度經審計歸屬上市公司股東的股東權益的1.31%。
本次公司投資旨在拓寬合作渠道,與合作方共同投資,促進公司業務的發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.